electroCore Inc

View in Terminal

Loading quotes...

Forecast

Buy	3
Hold	3
Sell	0

News Go to news feed

Electrocore reports strong revenue growth in Q4 2025, stock falls

Electrocore achieved a record revenue of $9.2 million in Q4 2025 (+31% year-on-year) and full-year revenue of $32 million (+27%). Gross margin improved to 87%, while net loss increased to $14 million and operating expenses rose by $7.3 million, after which the stock fell 5% to $6.90. For 2026 the company forecasts $42.54 million in revenue and plans to launch new products, including Quell Relief in H1 2026. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2022, electroCore Inc has already paid €0.049 in dividends. The last payout was in January 2022.

Financials

In the last quarter, electroCore Inc had revenue of €8.28m and net profit of -€2.68m

(EUR)	June 2026	YoY
Revenue	8.28m	32.23%
Gross profit	7.16m	31.09%
Net profit	-2.68m	13.94%
EBITDA	-2.37m	20.46%

Fundamentals

Metric	Value
Market capitalization	€60.61m
Number of shares	9.02m
52-week high/low	€11.35 - €3.94
Dividends	No
Beta	1.05
P/E ratio	-4.42
PEG ratio	1.07
P/B ratio	-25.35
P/S ratio	1.83

Company profile

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.